Lin, Fleming and DeGruttola (LFD) address the important problem of estimating the proportion of treatment effect (PTE) explained by a surrogate marker. Problems of interpretation of the measure as well as the theoretical basis of its formulation are well explained. This measure has been introduced t
ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER
β Scribed by D. Y. LIN; T. R. FLEMING; V. DE GRUTTOLA
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 362 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
β¦ Synopsis
In this paper, we measure the extent to which a biological marker is a surrogate endpoint for a clinical event by the proportional reduction in the regression coefficient for the treatment indicator due to the inclusion of the marker in the Cox regression model. We estimate this proportion by applying the partial likelihood function to two Cox models postulated on the same failure time variable. We show that the resultant estimator is asymptotically normal with a simple variance estimator. One can construct confidence intervals for the proportion by using the direct normal approximation to the point estimator or by using Fieller's theorem. Extensive simulation studies demonstrate that the proposed methods are appropriate for practical use. We provide applications to HIV/AIDS clinical trials.
π SIMILAR VOLUMES
The new US National Osteoporosis Foundation's (NOF's) __Clinician's Guide to Prevention and Treatment of Osteoporosis__ includes criteria for recommending pharmacologic treatment based on history of hip or vertebral fracture, femoral neck or spine bone mineral density (BMD) __T__-scores of β2.5 or l
## Abstract In this paper we introduce the Random Recursive Partitioning (RRP) matching method. RRP generates a proximity matrix which might be useful in econometric applications like average treatment effect estimation. RRP is a Monte Carlo method that randomly generates nonβempty recursive partit
Recurrent events are frequently encountered in clinical trials when individuals may experience an event more than once. Examples are common in medical research, including infectious episodes, myocardial infarctions and hospital admissions. However, when only the "rst event is considered, there is a
The study of receptor-ligand interactions by affinity capillary electrophoresis (ACE) requires an accurate form of analysis. Here, we examine the use of two noninteracting standards (markers) in the analysis of binding constant data in ACE studies. This concept is demonstrated using two model system